当前位置：
X-MOL 学术
›
Aliment. Pharm. Ther.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
XBB.1.5-Adapted COVID-19 mRNA Vaccines but Not Infections With Previous Omicron Variants Boost Neutralisation Against the SARS-CoV-2 JN.1 Variant in Patients With Inflammatory Bowel Disease
Alimentary Pharmacology & Therapeutics ( IF 6.6 ) Pub Date : 2024-10-29 , DOI: 10.1111/apt.18349 Simon Woelfel, Joel Dütschler, Daniel Junker, Marius König, Nicole Graf, Claudia Krieger, Samuel Truniger, Vasileios Oikonomou, Georg Leinenkugel, Seraina Koller, Katline Metzger-Peter, Jacqueline Wyss, Niklas Krupka, Nicola Frei, , Werner C. Albrich, Matthias Friedrich, Jan Hendrik Niess, Nicole Schneiderhan-Marra, Alex Dulovic, Benjamin Misselwitz, Wolfgang Korte, Justus J. Bürgi, Stephan Brand
Alimentary Pharmacology & Therapeutics ( IF 6.6 ) Pub Date : 2024-10-29 , DOI: 10.1111/apt.18349 Simon Woelfel, Joel Dütschler, Daniel Junker, Marius König, Nicole Graf, Claudia Krieger, Samuel Truniger, Vasileios Oikonomou, Georg Leinenkugel, Seraina Koller, Katline Metzger-Peter, Jacqueline Wyss, Niklas Krupka, Nicola Frei, , Werner C. Albrich, Matthias Friedrich, Jan Hendrik Niess, Nicole Schneiderhan-Marra, Alex Dulovic, Benjamin Misselwitz, Wolfgang Korte, Justus J. Bürgi, Stephan Brand
|
Variant-adapted COVID-19 vaccines are recommended for patients with inflammatory bowel disease (IBD). However, many patients rely on pre-existing immunity by original vaccines or prior infections.
中文翻译：
XBB.1.5 适应的 COVID-19 mRNA 疫苗而不是先前 Omicron 变体的感染增强了炎症性肠病患者对 SARS-CoV-2 JN.1 变体的中和
建议炎症性肠病 （IBD） 患者接种适应变异株的 COVID-19 疫苗。然而，许多患者依赖于原始疫苗或先前感染的先前存在的免疫力。
更新日期：2024-10-29
中文翻译：
XBB.1.5 适应的 COVID-19 mRNA 疫苗而不是先前 Omicron 变体的感染增强了炎症性肠病患者对 SARS-CoV-2 JN.1 变体的中和
建议炎症性肠病 （IBD） 患者接种适应变异株的 COVID-19 疫苗。然而，许多患者依赖于原始疫苗或先前感染的先前存在的免疫力。
京公网安备 11010802027423号